WELCOME
to the European leader in online investment in biotechnology and healthcare.
We connect private investors with the best start-up companies in European biomedicine.
The biotechnology revolution is underway. In the last fifteen years, the emergence of new technologies and new socioeconomic paradigms has radically changed the way we innovate and invest in the future of our health.
As a result, biotechnology has become one of the largest and most profitable investment sectors in the world. A quarter of the world's venture capital investment goes to this sector, with returns that have been exceeding 20% per year for many years.
Capital Cell opens up a channel of access for private investors to an asset that, until now, was reserved for a few specialists or large fortunes.
This platform was born to make available to everyone the work of a highly specialized team of professional investors, lawyers, financiers, scientists and health experts from around the world.
You have never had it so easy to invest in the most profitable sector with the greatest social impact.
"Thanks to our platform, anyone can invest alongside professional institutions and investors, with affordable minimum investments for everyone."
Together with a global network of science and investment experts, we select the best innovative companies with high profitability potential.
Our value proposition consists of reducing the risk of investing in biotechnology thanks to the in-depth analysis we carry out on companies.
Start of activity: 2015
Headquarters: Barcelona
Operating Headquarters: Barcelona
Founders: Daniel Oliver
Activity license: PFP , license CNMV nº17
Employees: 7
Average size of rounds: €880,000
Largest round: €2,000,000
Nice to meet you
We are a team of experts in investment, science and finance.
Technology is our ally - it allows us to offer an efficient and fast service to investors and companies - but we still believe that human relationships are essential when it comes to generating value:
we provide care 100% personalizedto both investors and companies.
Board of directors and advisors
We are convinced that we are backed by the best.
They are all deeply involved in the company's management and decision-making processes, and the operations of Capital Cell benefit daily from their participation.
Jordi is an entrepreneur, investor and advisor. He was part of the Center for Genomic Regulation in Barcelona, where he worked with TBDO identifying investment opportunities in the biotech market. He brings to Capital Cell both his knowledge and passion for biotechnology and his know-how in the creation of a successful company, from its foundation to its sale.
Nigel has a long track record in biotech startups. He is on the board of 12 companies, 7 of which he founded. He is founder of Athena Diagnostics, sold for $740 million, professor at Harvard Medical School and ESADE Barcelona and co-inventor of 8 patents.
Xavier holds an MBA from ESADE Barcelona and has extensive experience managing companies specialized in the banking and investment sector, from their accelerated growth phase to their IPO. He is a member of the board of directors of several technology and scientific companies.
Joan is a Senior Software Developer with extensive experience in analysis, design, development and implementation of various internet applications and Blockchain expert. He has founded, managed and successfully sold two Engineering companies. He leads the vision and technology development at Capital Cell.
Want to know more about Capital Cell?
Our partners
Capital Cell collaborates openly with scientific, investment and entrepreneurship entities.
